Safety and efficacy of soluble guanylate cyclase stimulators in patients with heart failure: A systematic review and meta-analysis

BACKGROUND: The utility of novel oral soluble guanylate cyclase (sGC) stimulators (vericiguat and riociguat), in patients with reduced or preserved ejection fraction heart failure (HFrEF/HFpEF) is currently unclear. AIM: To determine the efficacy and safety of sGC stimulators in HF patients. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullah, Waqas, Mukhtar, Maryam, Al-Mukhtar, Aws, Saeed, Rehan, Boigon, Margot, Haas, Donald, Rame, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596421/
https://www.ncbi.nlm.nih.gov/pubmed/33173569
http://dx.doi.org/10.4330/wjc.v12.i10.501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596421/
https://www.ncbi.nlm.nih.gov/pubmed/33173569
http://dx.doi.org/10.4330/wjc.v12.i10.501

Ejemplares similares